Detalhe da pesquisa
1.
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile.
Int J Mol Sci
; 25(3)2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339198
2.
A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas.
Neuroendocrinology
; 106(2): 116-127, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28384628
3.
Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptor.
Bioconjug Chem
; 26(6): 1113-9, 2015 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25971921
4.
Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate Cancer.
Mol Pharm
; 12(8): 2781-90, 2015 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26132879
5.
Does somatostatin or gastric inhibitory peptide receptor expression correlate with tumor grade and stage in gut neuroendocrine tumors?
Neuroendocrinology
; 101(1): 45-57, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25591947
6.
Early over-expression of GRP receptors in prostatic carcinogenesis.
Prostate
; 74(2): 217-24, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24150752
7.
Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues.
Eur J Nucl Med Mol Imaging
; 41(6): 1166-71, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24519555
8.
Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma.
Pituitary
; 17(3): 227-31, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740146
9.
Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.
Am J Pathol
; 180(5): 1942-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22538189
10.
Old and new peptide receptor targets in cancer: future directions.
Recent Results Cancer Res
; 194: 567-76, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22918784
11.
Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing ß-amino acid residues - a lesson about the importance of animal experiments.
Chem Biodivers
; 10(12): 2101-21, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24327436
12.
Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 39(12): 1876-85, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22926735
13.
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Gastroenterology
; 139(3): 742-53, 753.e1, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20637207
14.
Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans.
Eur J Nucl Med Mol Imaging
; 38(6): 1054-8, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21210113
15.
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.
Eur J Nucl Med Mol Imaging
; 38(1): 97-107, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20717822
16.
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.
Eur J Nucl Med Mol Imaging
; 38(8): 1426-35, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21528387
17.
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides.
Eur J Nucl Med Mol Imaging
; 38(8): 1410-6, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21461732
18.
Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.
Eur J Nucl Med Mol Imaging
; 38(8): 1417-25, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21523391
19.
Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy.
Neuroendocrinology
; 94(4): 291-301, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21893952
20.
On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.
Chem Biodivers
; 8(5): 711-39, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21560227